세계의 식물 유래 원료의약품(API) 시장 보고서(2025년)

Plant-Based Active Pharmaceutical Ingredients (API) Global Market Report 2025

US $ 4,490 ￦ 6,156,000

PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 6,490 ￦ 8,898,000

PDF (Site License)

PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 8,490 ￦ 11,640,000

PDF (Enterprise License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

한글목차

식물 유래 원료의약품(API) 시장 규모는 향후 몇 년 동안 강력한 성장을 보일 것으로 예상되며, 2029년까지 연평균 성장률(CAGR) 6.9%로 423억 4,400만 달러에 달할 것으로 예상됩니다. 예측 기간 동안의 성장은 천연물 의약품에 대한 소비자 선호도 증가, 식물 유래 의약품 연구에 대한 투자 증가, 만성질환 치료에 대한 용도 확대, 제약 산업과 식물 의약품 산업의 협력 관계 확대 등의 요인에 기인하는 것으로 보입니다. 이 기간의 주요 동향으로는 AI를 활용한 신약 개발, 첨단 식물 조직 배양 기술, 식물 유래 화합물의 정밀 발효, 지속가능한 생산을 위한 그린 추출법 등이 있습니다.

천연 및 유기농 제품에 대한 소비자 수요 증가는 식물 유래 원료의약품(API) 시장의 성장을 견인할 것으로 예상됩니다. 천연-유기농 제품은 자연에서 유래한 원료를 사용하고 가공을 최소화하며 합성화학제품이나 유전자 변형작물(GMO)을 사용하지 않은 제품을 말합니다. 이러한 천연-유기농 제품으로의 전환은 합성 화학제품에 대한 건강 인식과 우려가 높아지면서 소비자들이 합성 성분과 관련된 잠재적 위험에 대해 더 많이 인식하게 되었기 때문입니다. 식물에서 추출한 원료의약품(API)은 깨끗하고 안전하며 지속가능한 건강관리 옵션을 원하는 소비자의 선호에 따라 화학제품 없이 효과적인 약효를 제공함으로써 이러한 수요에 부응하고 있습니다. 예를 들어, 2024년 5월 아르헨티나의 유기농 인증 기관인 LETIS S.A.는 2022년 유기농 식품 매출이 616억 7,000만 달러에 달해 전년 대비 4.3% 증가했다고 발표했습니다. 또한 기타 유기농 제품도 1.6% 성장한 59억 600만 달러에 달했습니다. 그 결과, 천연 및 유기농 제품에 대한 선호도가 높아지면서 식물성 원료의약품(API) 시장 확대에 박차를 가하고 있습니다.

식물 유래 원료의약품(API) 시장의 주요 기업들은 기존의 동물성 원료에 대한 지속가능하고 윤리적인 대안을 제공하는 식물 유래 스쿠알렌과 같은 혁신적인 솔루션 개발에 주력하고 있습니다. 아마란스, 올리브, 사탕수수 등 식물에서 추출한 식물성 스쿠알렌은 의약품, 화장품, 백신에서 상어에서 추출한 스쿠알렌을 대체할 수 있는 윤리적 대안이 될 수 있습니다. 예를 들어, 2023년 10월 독일에 본사를 둔 특수 화학 기업 Evonik Industries AG는 아마란스 오일을 원료로 한 최초의 GMP 품질의 식물성 스쿠알렌 PhytoSquene을 출시했습니다. 이 혁신은 상어에서 추출한 스쿠알렌을 대체할 수 있는 지속가능한 대안을 제공하며, 고순도, 일관된 배치 품질, 유럽 약전(Ph.Eur.) 표준 준수를 보장합니다. 스쿠알렌은 면역 반응을 향상시키기 때문에 백신 보조제의 중요한 성분입니다. 식물 유래 버전을 제공함으로써 PhytoSquene은 생물 다양성에 대한 우려에 대응하고 동물성 공급원에 대한 의존도를 낮추며 문화적, 종교적 선호를 존중합니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 - 금리, 인플레이션, 지정학, 무역 전쟁과 관세, 그리고 코로나와 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

• 세계 식물 유래 원료의약품(API) PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
• 최종 이용 산업 분석
• 세계의 식물 유래 원료의약품(API) 시장 : 성장률 분석
• 세계의 식물 유래 원료의약품(API) 시장 실적 : 규모와 성장, 2019-2024
• 세계의 식물 유래 원료의약품(API) 시장 예측 : 규모와 성장, 2024-2029, 2034F
• 세계 식물 유래 원료의약품(API) 전체 시장(TAM)

제6장 시장 세분화

• 세계의 식물 유래 원료의약품(API) 시장 : 제품 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
• 알칼로이드
• 배당체
• 카나비노이드
• 플라보노이드
• 테르펜과 테르페노이드
• 폴리페놀
• 사포닌
• 기타 제품 유형
• 세계의 식물 유래 원료의약품(API) 시장 : 소스별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
• 잎
• 뿌리
• 나무껍질
• 꽃
• 씨앗
• 열매
• 수지와 껌
• 기타 소스
• 세계의 식물 유래 원료의약품(API) 시장 : 유통 채널별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
• 온라인 소매업체
• 슈퍼마켓 또는 하이퍼마켓
• 전문 식품점
• 푸드서비스
• 세계의 식물 유래 원료의약품(API) 시장 : 최종 용도별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
• 의약품
• 뉴트라슈티컬
• 허브 관련 산업
• 기타 용도
• 세계의 식물 유래 원료의약품(API) 시장 알칼로이드 종류별 하위 세분화, 실적과 예측, 2019-2024, 2024-2029F, 2034F
• 모르핀 알칼로이드
• 트로판 알칼로이드
• 퀴놀리지딘 알칼로이드
• 인돌 알칼로이드
• 이소퀴놀린 알칼로이드
• 피롤리지딘 알칼로이드
• 세계의 식물 유래 원료의약품(API) 시장, 배당체 하위 세분화, 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
• 심장 배당체
• 안트라퀴논 배당체
• 플라보노이드 배당체
• 사포닌 배당체
• 시아노제닉 배당체
• 세계의 식물 유래 원료의약품(API) 시장 카나비노이드 종류별 하위 세분화, 실적과 예측, 2019-2024, 2024-2029F, 2034F
• 테트라하이드로칸나비놀(THC)
• 칸나비디올(CBD)
• 칸나비게롤(CBG)
• 칸나비크로멘(CBC)
• 칸나비놀(CBN)
• 세계의 식물 유래 원료의약품(API) 시장 플라보노이드 종류별 하위 세분화, 실적과 예측, 2019-2024, 2024-2029F, 2034F
• 플라본
• 플라보놀
• 이소플라본
• 플라바논
• 안토시아닌
• 세계의 식물 유래 원료의약품(API) 시장 테르펜과 테르페노이드 종류별 하위 세분화, 실적과 예측, 2019-2024, 2024-2029F, 2034F
• 모노테르펜
• 세스퀴테르펜
• 디테르펜
• 트리테르펜
• 테트라테르펜
• 세계의 식물 유래 원료의약품(API) 시장 폴리페놀 종류별 하위 세분화, 실적과 예측, 2019-2024, 2024-2029F, 2034F
• 페놀산
• 스틸벤
• 리그난
• 플라보노이드 폴리페놀
• 세계의 식물 유래 원료의약품(API) 시장 사포닌 종류별 하위 세분화, 실적과 예측, 2019-2024, 2024-2029F, 2034F
• 스테로이드사포닌
• 트리테르페노이드사포닌
• 세계의 식물 유래 원료의약품(API) 시장, 기타 제품 유형 하위 세분화, 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
• 쿠마린
• 타닌
• 리그닌
• 페놀 배당체

제7장 지역별·국가별 분석

• 세계의 식물 유래 원료의약품(API) 시장 : 지역별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
• 세계의 식물 유래 원료의약품(API) 시장 : 국가별, 실적과 예측, 2019-2024, 2024-2029F, 2034F

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 개요

• 식물 유래 원료의약품(API) 시장 : 경쟁 구도
• 식물 유래 원료의약품(API) 시장 : 기업 개요
  • Evonik Industries AG Overview, Products and Services, Strategy and Financial Analysis
  • Roquette Freres Overview, Products and Services, Strategy and Financial Analysis
  • Sun Pharmaceutical Industries Ltd Overview, Products and Services, Strategy and Financial Analysis
  • Aurobindo Pharma Overview, Products and Services, Strategy and Financial Analysis
  • Koninklijke DSM NV Overview, Products and Services, Strategy and Financial Analysis

제31장 기타 주요 기업과 혁신적 기업

• Alembic Pharmaceuticals Ltd
• Seppic
• Indena SpA
• PAI Pharma
• Centroflora Group
• Alkaloids Corporation
• SCL Lifesciences Ltd
• Alchem International Pvt Ltd
• AMGIS Lifescience Ltd
• C2 Pharma
• PhytoHealth Corp
• Bright Green Corporation
• Sichuan Xieli Pharmaceutical Co Ltd
• Brains Bioceutical Corp
• Organotechnie

제32장 세계의 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병

제34장 최근의 시장 동향

제35장 시장 잠재력이 높은 국가, 부문, 전략

• 식물 유래 원료의약품(API) 시장 2029 : 새로운 기회를 제공하는 국가
• 식물 유래 원료의약품(API) 시장 2029 : 새로운 기회를 제공하는 부문
• 식물 유래 원료의약품(API) 시장 2029 : 성장 전략
  • 시장 동향에 기반한 전략
  • 경쟁 전략

제36장 부록

ksm

영문 목차

영문목차

Plant-based active pharmaceutical ingredients (APIs) are biologically active compounds derived from plants and are essential in the formulation of medications. These ingredients are important for their therapeutic effects, which can include treating, preventing, or managing various health conditions.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The main product types of plant-based active pharmaceutical ingredients (APIs) include alkaloids, glycosides, cannabinoids, flavonoids, terpenes and terpenoids, polyphenols, saponins, and others. Alkaloids are a diverse group of naturally occurring organic compounds, most of which contain basic nitrogen atoms. Plant-based active pharmaceutical ingredients (APIs) are sourced from various plant parts, including leaves, roots, bark, flowers, seeds, fruits, resins, gums, and other natural sources. These ingredients are distributed through various channels, such as online retailers, supermarkets and hypermarkets, specialty food stores, and foodservice providers, and are widely used across industries such as pharmaceuticals, nutraceuticals, herbal-based industries, and others.

The plant-based active pharmaceutical ingredients (API) market research report is one of a series of new reports from The Business Research Company that provides plant-based active pharmaceutical ingredients (API) market statistics, including plant-based active pharmaceutical ingredients (API) industry global market size, regional shares, competitors with a plant-based active pharmaceutical ingredients (API) market share, detailed plant-based active pharmaceutical ingredients (API) market segments, market trends and opportunities, and any further data you may need to thrive in the plant-based active pharmaceutical ingredients (API) industry. This plant-based active pharmaceutical ingredients (API) market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The plant-based active pharmaceutical ingredients (API) market size has grown strongly in recent years. It will grow from$30.22 billion in 2024 to $32.39 billion in 2025 at a compound annual growth rate (CAGR) of 7.2%. The growth during the historic period can be attributed to factors such as the increasing use of traditional herbal medicine practices, a growing demand for natural remedies, the rise of early pharmaceutical formulations, the expanding global trade of medicinal herbs, and the increasing industrialization of botanical drugs.

The plant-based active pharmaceutical ingredients (API) market size is expected to see strong growth in the next few years. It will grow to$42.34 billion in 2029 at a compound annual growth rate (CAGR) of 6.9%. The growth during the forecast period can be attributed to factors such as rising consumer preference for natural medicines, increasing investment in plant-based drug research, expanding applications in the treatment of chronic diseases, and growing collaborations between the pharmaceutical and botanical industries. Key trends during this period include AI-driven drug discovery, advanced plant tissue culture techniques, precision fermentation for plant-derived compounds, and green extraction methods aimed at sustainable production.

The rising consumer demand for natural and organic products is expected to drive the growth of the plant-based active pharmaceutical ingredients (API) market. Natural and organic products are those made from ingredients that are naturally sourced, minimally processed, and free from synthetic chemicals and genetically modified organisms (GMOs). This shift towards natural and organic products is largely due to increased health awareness and concerns over synthetic chemicals, with consumers becoming more conscious of the potential risks associated with synthetic ingredients. Plant-based active pharmaceutical ingredients (APIs) cater to this demand by providing effective, chemical-free medicinal benefits that align with the consumer preference for clean, safe, and sustainable healthcare options. For example, in May 2024, LETIS S.A., an Argentina-based organic certification authority, reported that organic food sales reached $61.67 billion in 2022, marking a 4.3% increase from the previous period. Additionally, other organic products contributed $5.906 billion, reflecting a 1.6% growth. As a result, the growing preference for natural and organic products is fueling the expansion of the plant-based active pharmaceutical ingredients (API) market.

Leading companies in the plant-based active pharmaceutical ingredients (API) market are focusing on developing innovative solutions such as plant-based squalene, which offer sustainable and ethical alternatives to traditional animal-derived sources. Plant-based squalene, derived from plants such as amaranth, olives, and sugarcane, serves as an ethical substitute for shark-derived squalene in pharmaceuticals, cosmetics, and vaccines. For instance, in October 2023, Evonik Industries AG, a Germany-based specialty chemicals company, launched PhytoSquene, the first GMP-quality, plant-based squalene sourced from amaranth oil. This innovation provides a sustainable alternative to shark-derived squalene, ensuring high purity, consistent batch quality, and compliance with European Pharmacopoeia (Ph. Eur.) standards. Squalene is an important ingredient in vaccine adjuvants, as it enhances the immune response. By offering a plant-based version, PhytoSquene addresses concerns about biodiversity, reduces reliance on animal-derived sources, and respects cultural and religious preferences.

In March 2024, Roquette Freres, a France-based provider of pharmaceutical excipients, acquired IFF Pharma Solutions for an undisclosed sum. This acquisition aims to strengthen Roquette's position in the pharmaceutical excipients market by broadening its product portfolio and expertise in drug delivery. This move is expected to accelerate Roquette's growth in the health and nutrition sectors, positioning the company as a key partner for pharmaceutical companies. IFF Pharma Solutions, a US-based pharmaceutical company, specializes in offering plant-based active pharmaceutical ingredients.

Major players in the plant-based active pharmaceutical ingredients (API) market are Evonik Industries AG, Roquette Freres, Sun Pharmaceutical Industries Ltd, Aurobindo Pharma, Koninklijke DSM NV, Alembic Pharmaceuticals Ltd, Seppic, Indena SpA, PAI Pharma, Centroflora Group, Alkaloids Corporation, SCL Lifesciences Ltd, Alchem International Pvt Ltd, AMGIS Lifescience Ltd, C2 Pharma, PhytoHealth Corp, Bright Green Corporation, Sichuan Xieli Pharmaceutical Co Ltd, Brains Bioceutical Corp, Organotechnie, and HimPharm.

North America was the largest region in the plant-based active pharmaceutical ingredients (API) market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in plant-based active pharmaceutical ingredients (API) report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the plant-based active pharmaceutical ingredients (API) market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The plant-based active pharmaceutical ingredients (API) market consists of sales of botanical extracts, plant-based steroids, essential oils, flavonoids, and botanical extracts. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Plant-Based Active Pharmaceutical Ingredients (API) Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on plant-based active pharmaceutical ingredients (api) market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for plant-based active pharmaceutical ingredients (api) ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The plant-based active pharmaceutical ingredients (api) market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product Type: Alkaloids; Glycosides; Cannabinoids; Flavonoid; Terpenes And Terpenoids; Polyphenols; Saponins; Other Product Types
• 2) By Source: Leaves; Roots; Bark; Flowers; Seeds; Fruits; Resin And Gums; Other Sources
• 3) By Distribution Channel: Online Retailers; Supermarkets Or Hypermarkets; Specialty Food Stores; Foodservice
• 4) By End-Use: Pharmaceuticals; Nutraceuticals; Herbal Based Industries; Other End-Uses
• Subsegments:
• 1) Alkaloids: Morphine Alkaloids; Tropane Alkaloids; Quinolizidine Alkaloids; Indole Alkaloids; Isoquinoline Alkaloids; Pyrrolizidine Alkaloids
• 2) By Glycosides: Cardiac Glycosides; Anthraquinone Glycosides; Flavonoid Glycosides; Saponin Glycosides; Cyanogenic Glycosides
• 3) Cannabinoids: Tetrahydrocannabinol (THC); Cannabidiol (CBD); Cannabigerol (CBG); Cannabichromene (CBC); Cannabinol (CBN)
• 4) Flavonoid: Flavones; Flavonols; Isoflavones; Flavanones; Anthocyanins
• 5) Terpenes And Terpenoids: Monoterpenes; Sesquiterpenes; Diterpenes; Triterpenes; Tetraterpenes
• 6) Polyphenols: Phenolic Acids; Stilbenes; Lignans; Flavonoid Polyphenols
• 7) Saponins: Steroidal Saponins; Triterpenoid Saponins
• 8) Other Product Types: Coumarins; Tannins; Lignins; Phenolic Glycosides
• Companies Mentioned: Evonik Industries AG; Roquette Freres; Sun Pharmaceutical Industries Ltd; Aurobindo Pharma; Koninklijke DSM NV
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Plant-Based Active Pharmaceutical Ingredients (API) Market Characteristics

3. Plant-Based Active Pharmaceutical Ingredients (API) Market Trends And Strategies

4. Plant-Based Active Pharmaceutical Ingredients (API) Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Plant-Based Active Pharmaceutical Ingredients (API) Growth Analysis And Strategic Analysis Framework

• 5.1. Global Plant-Based Active Pharmaceutical Ingredients (API) PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Plant-Based Active Pharmaceutical Ingredients (API) Market Growth Rate Analysis
• 5.4. Global Plant-Based Active Pharmaceutical Ingredients (API) Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Plant-Based Active Pharmaceutical Ingredients (API) Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Plant-Based Active Pharmaceutical Ingredients (API) Total Addressable Market (TAM)

6. Plant-Based Active Pharmaceutical Ingredients (API) Market Segmentation

• 6.1. Global Plant-Based Active Pharmaceutical Ingredients (API) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Alkaloids
• Glycosides
• Cannabinoids
• Flavonoid
• Terpenes And Terpenoids
• Polyphenols
• Saponins
• Other Product Types
• 6.2. Global Plant-Based Active Pharmaceutical Ingredients (API) Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Leaves
• Roots
• Bark
• Flowers
• Seeds
• Fruits
• Resin And Gums
• Other Sources
• 6.3. Global Plant-Based Active Pharmaceutical Ingredients (API) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Online Retailers
• Supermarkets Or Hypermarkets
• Specialty Food Stores
• Foodservice
• 6.4. Global Plant-Based Active Pharmaceutical Ingredients (API) Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Pharmaceuticals
• Nutraceuticals
• Herbal Based Industries
• Other End-Uses
• 6.5. Global Plant-Based Active Pharmaceutical Ingredients (API) Market, Sub-Segmentation Of Alkaloids, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Morphine Alkaloids
• Tropane Alkaloids
• Quinolizidine Alkaloids
• Indole Alkaloids
• Isoquinoline Alkaloids
• Pyrrolizidine Alkaloids
• 6.6. Global Plant-Based Active Pharmaceutical Ingredients (API) Market, Sub-Segmentation Of Glycosides, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Cardiac Glycosides
• Anthraquinone Glycosides
• Flavonoid Glycosides
• Saponin Glycosides
• Cyanogenic Glycosides
• 6.7. Global Plant-Based Active Pharmaceutical Ingredients (API) Market, Sub-Segmentation Of Cannabinoids, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Tetrahydrocannabinol (THC)
• Cannabidiol (CBD)
• Cannabigerol (CBG)
• Cannabichromene (CBC)
• Cannabinol (CBN)
• 6.8. Global Plant-Based Active Pharmaceutical Ingredients (API) Market, Sub-Segmentation Of Flavonoid, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Flavones
• Flavonols
• Isoflavones
• Flavanones
• Anthocyanins
• 6.9. Global Plant-Based Active Pharmaceutical Ingredients (API) Market, Sub-Segmentation Of Terpenes And Terpenoids, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Monoterpenes
• Sesquiterpenes
• Diterpenes
• Triterpenes
• Tetraterpenes
• 6.10. Global Plant-Based Active Pharmaceutical Ingredients (API) Market, Sub-Segmentation Of Polyphenols, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Phenolic Acids
• Stilbenes
• Lignans
• Flavonoid Polyphenols
• 6.11. Global Plant-Based Active Pharmaceutical Ingredients (API) Market, Sub-Segmentation Of Saponins, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Steroidal Saponins
• Triterpenoid Saponins
• 6.12. Global Plant-Based Active Pharmaceutical Ingredients (API) Market, Sub-Segmentation Of Other Product Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Coumarins
• Tannins
• Lignins
• Phenolic Glycosides

7. Plant-Based Active Pharmaceutical Ingredients (API) Market Regional And Country Analysis

• 7.1. Global Plant-Based Active Pharmaceutical Ingredients (API) Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Plant-Based Active Pharmaceutical Ingredients (API) Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Plant-Based Active Pharmaceutical Ingredients (API) Market

• 8.1. Asia-Pacific Plant-Based Active Pharmaceutical Ingredients (API) Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Plant-Based Active Pharmaceutical Ingredients (API) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Plant-Based Active Pharmaceutical Ingredients (API) Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Plant-Based Active Pharmaceutical Ingredients (API) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Plant-Based Active Pharmaceutical Ingredients (API) Market

• 9.1. China Plant-Based Active Pharmaceutical Ingredients (API) Market Overview
• 9.2. China Plant-Based Active Pharmaceutical Ingredients (API) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Plant-Based Active Pharmaceutical Ingredients (API) Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Plant-Based Active Pharmaceutical Ingredients (API) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Plant-Based Active Pharmaceutical Ingredients (API) Market

• 10.1. India Plant-Based Active Pharmaceutical Ingredients (API) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Plant-Based Active Pharmaceutical Ingredients (API) Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Plant-Based Active Pharmaceutical Ingredients (API) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Plant-Based Active Pharmaceutical Ingredients (API) Market

• 11.1. Japan Plant-Based Active Pharmaceutical Ingredients (API) Market Overview
• 11.2. Japan Plant-Based Active Pharmaceutical Ingredients (API) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Plant-Based Active Pharmaceutical Ingredients (API) Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Plant-Based Active Pharmaceutical Ingredients (API) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Plant-Based Active Pharmaceutical Ingredients (API) Market

• 12.1. Australia Plant-Based Active Pharmaceutical Ingredients (API) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Plant-Based Active Pharmaceutical Ingredients (API) Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Plant-Based Active Pharmaceutical Ingredients (API) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Plant-Based Active Pharmaceutical Ingredients (API) Market

• 13.1. Indonesia Plant-Based Active Pharmaceutical Ingredients (API) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Plant-Based Active Pharmaceutical Ingredients (API) Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Plant-Based Active Pharmaceutical Ingredients (API) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Plant-Based Active Pharmaceutical Ingredients (API) Market

• 14.1. South Korea Plant-Based Active Pharmaceutical Ingredients (API) Market Overview
• 14.2. South Korea Plant-Based Active Pharmaceutical Ingredients (API) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Plant-Based Active Pharmaceutical Ingredients (API) Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Plant-Based Active Pharmaceutical Ingredients (API) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Plant-Based Active Pharmaceutical Ingredients (API) Market

• 15.1. Western Europe Plant-Based Active Pharmaceutical Ingredients (API) Market Overview
• 15.2. Western Europe Plant-Based Active Pharmaceutical Ingredients (API) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Plant-Based Active Pharmaceutical Ingredients (API) Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Plant-Based Active Pharmaceutical Ingredients (API) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Plant-Based Active Pharmaceutical Ingredients (API) Market

• 16.1. UK Plant-Based Active Pharmaceutical Ingredients (API) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Plant-Based Active Pharmaceutical Ingredients (API) Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Plant-Based Active Pharmaceutical Ingredients (API) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Plant-Based Active Pharmaceutical Ingredients (API) Market

• 17.1. Germany Plant-Based Active Pharmaceutical Ingredients (API) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Plant-Based Active Pharmaceutical Ingredients (API) Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Plant-Based Active Pharmaceutical Ingredients (API) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Plant-Based Active Pharmaceutical Ingredients (API) Market

• 18.1. France Plant-Based Active Pharmaceutical Ingredients (API) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Plant-Based Active Pharmaceutical Ingredients (API) Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Plant-Based Active Pharmaceutical Ingredients (API) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Plant-Based Active Pharmaceutical Ingredients (API) Market

• 19.1. Italy Plant-Based Active Pharmaceutical Ingredients (API) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Plant-Based Active Pharmaceutical Ingredients (API) Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Plant-Based Active Pharmaceutical Ingredients (API) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Plant-Based Active Pharmaceutical Ingredients (API) Market

• 20.1. Spain Plant-Based Active Pharmaceutical Ingredients (API) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Plant-Based Active Pharmaceutical Ingredients (API) Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Plant-Based Active Pharmaceutical Ingredients (API) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Plant-Based Active Pharmaceutical Ingredients (API) Market

• 21.1. Eastern Europe Plant-Based Active Pharmaceutical Ingredients (API) Market Overview
• 21.2. Eastern Europe Plant-Based Active Pharmaceutical Ingredients (API) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Plant-Based Active Pharmaceutical Ingredients (API) Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Plant-Based Active Pharmaceutical Ingredients (API) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Plant-Based Active Pharmaceutical Ingredients (API) Market

• 22.1. Russia Plant-Based Active Pharmaceutical Ingredients (API) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Plant-Based Active Pharmaceutical Ingredients (API) Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Plant-Based Active Pharmaceutical Ingredients (API) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Plant-Based Active Pharmaceutical Ingredients (API) Market

• 23.1. North America Plant-Based Active Pharmaceutical Ingredients (API) Market Overview
• 23.2. North America Plant-Based Active Pharmaceutical Ingredients (API) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Plant-Based Active Pharmaceutical Ingredients (API) Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Plant-Based Active Pharmaceutical Ingredients (API) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Plant-Based Active Pharmaceutical Ingredients (API) Market

• 24.1. USA Plant-Based Active Pharmaceutical Ingredients (API) Market Overview
• 24.2. USA Plant-Based Active Pharmaceutical Ingredients (API) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Plant-Based Active Pharmaceutical Ingredients (API) Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Plant-Based Active Pharmaceutical Ingredients (API) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Plant-Based Active Pharmaceutical Ingredients (API) Market

• 25.1. Canada Plant-Based Active Pharmaceutical Ingredients (API) Market Overview
• 25.2. Canada Plant-Based Active Pharmaceutical Ingredients (API) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Plant-Based Active Pharmaceutical Ingredients (API) Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Plant-Based Active Pharmaceutical Ingredients (API) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Plant-Based Active Pharmaceutical Ingredients (API) Market

• 26.1. South America Plant-Based Active Pharmaceutical Ingredients (API) Market Overview
• 26.2. South America Plant-Based Active Pharmaceutical Ingredients (API) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Plant-Based Active Pharmaceutical Ingredients (API) Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Plant-Based Active Pharmaceutical Ingredients (API) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Plant-Based Active Pharmaceutical Ingredients (API) Market

• 27.1. Brazil Plant-Based Active Pharmaceutical Ingredients (API) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Plant-Based Active Pharmaceutical Ingredients (API) Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Plant-Based Active Pharmaceutical Ingredients (API) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Plant-Based Active Pharmaceutical Ingredients (API) Market

• 28.1. Middle East Plant-Based Active Pharmaceutical Ingredients (API) Market Overview
• 28.2. Middle East Plant-Based Active Pharmaceutical Ingredients (API) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Plant-Based Active Pharmaceutical Ingredients (API) Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Plant-Based Active Pharmaceutical Ingredients (API) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Plant-Based Active Pharmaceutical Ingredients (API) Market

• 29.1. Africa Plant-Based Active Pharmaceutical Ingredients (API) Market Overview
• 29.2. Africa Plant-Based Active Pharmaceutical Ingredients (API) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Plant-Based Active Pharmaceutical Ingredients (API) Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Plant-Based Active Pharmaceutical Ingredients (API) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Plant-Based Active Pharmaceutical Ingredients (API) Market Competitive Landscape And Company Profiles

• 30.1. Plant-Based Active Pharmaceutical Ingredients (API) Market Competitive Landscape
• 30.2. Plant-Based Active Pharmaceutical Ingredients (API) Market Company Profiles
  • 30.2.1. Evonik Industries AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Roquette Freres Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Sun Pharmaceutical Industries Ltd Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Aurobindo Pharma Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Koninklijke DSM NV Overview, Products and Services, Strategy and Financial Analysis

31. Plant-Based Active Pharmaceutical Ingredients (API) Market Other Major And Innovative Companies

• 31.1. Alembic Pharmaceuticals Ltd
• 31.2. Seppic
• 31.3. Indena SpA
• 31.4. PAI Pharma
• 31.5. Centroflora Group
• 31.6. Alkaloids Corporation
• 31.7. SCL Lifesciences Ltd
• 31.8. Alchem International Pvt Ltd
• 31.9. AMGIS Lifescience Ltd
• 31.10. C2 Pharma
• 31.11. PhytoHealth Corp
• 31.12. Bright Green Corporation
• 31.13. Sichuan Xieli Pharmaceutical Co Ltd
• 31.14. Brains Bioceutical Corp
• 31.15. Organotechnie

32. Global Plant-Based Active Pharmaceutical Ingredients (API) Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Plant-Based Active Pharmaceutical Ingredients (API) Market

34. Recent Developments In The Plant-Based Active Pharmaceutical Ingredients (API) Market

35. Plant-Based Active Pharmaceutical Ingredients (API) Market High Potential Countries, Segments and Strategies

• 35.1 Plant-Based Active Pharmaceutical Ingredients (API) Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Plant-Based Active Pharmaceutical Ingredients (API) Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Plant-Based Active Pharmaceutical Ingredients (API) Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer
• 250617_r34929_Plant_Based_Active_Pharmaceutical_Ingredients_API_GMR_2025

관련자료